In high-risk adults, the Moderna vaccine had 94%...

In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose.

Abstract

SOURCE CITATION: Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384:403-16. 33378609.

Authors

Chagla Z

Journal

Annals of Internal Medicine, Vol. 174, No. 3,

Publisher

American College of Physicians

Publication Date

March 1, 2021

DOI

10.7326/acpj202103160-028

ISSN

1056-8751

Associated Experts

Zain Chagla

Associate Professor, FHSMED

Visit profile

Labels

In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose.

Abstract

Authors

Journal

Publisher

Publication Date

DOI

ISSN

Associated Experts

Labels

Fields of Research (FoR)

Sustainable Development Goals (SDG)

Medical Subject Headings (MeSH)

Contact the Experts team